A detailed history of Osterweis Capital Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Osterweis Capital Management Inc holds 3,531 shares of BMY stock, worth $200,137. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,531
Previous 3,531 -0.0%
Holding current value
$200,137
Previous $146,000 24.66%
% of portfolio
0.01%
Previous 0.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$40.25 - $52.99 $48,622 - $64,011
-1,208 Reduced 25.49%
3,531 $146,000
Q1 2024

May 15, 2024

SELL
$47.98 - $54.4 $14,873 - $16,864
-310 Reduced 6.14%
4,739 $256,000
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $132,007 - $146,573
2,072 Added 69.6%
5,049 $322,000
Q1 2022

May 16, 2022

BUY
$61.48 - $73.72 $183,025 - $219,464
2,977 New
2,977 $217,000
Q2 2020

Aug 14, 2020

SELL
$54.82 - $64.09 $246,525 - $288,212
-4,497 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$46.4 - $67.43 $79,436 - $115,440
-1,712 Reduced 27.57%
4,497 $251,000
Q4 2019

Feb 14, 2020

SELL
$49.21 - $64.19 $15,009 - $19,577
-305 Reduced 4.68%
6,209 $399,000
Q3 2019

Nov 14, 2019

BUY
$42.77 - $50.71 $13,044 - $15,466
305 Added 4.91%
6,514 $330,000
Q2 2019

Aug 14, 2019

SELL
$44.62 - $49.34 $315,909 - $349,327
-7,080 Reduced 53.28%
6,209 $281,000
Q2 2018

Aug 13, 2018

SELL
$50.53 - $62.98 $62,354 - $77,717
-1,234 Reduced 8.5%
13,289 $736,000
Q3 2017

Nov 13, 2017

BUY
$55.23 - $63.74 $802,105 - $925,696
14,523
14,523 $926,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $121B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Osterweis Capital Management Inc Portfolio

Follow Osterweis Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Osterweis Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Osterweis Capital Management Inc with notifications on news.